The new technique uncovers hidden inflammation in patients who, despite undergoing extensive treatment for the condition, had worsening symptoms.

Fast Track designations are typically granted to drugs that target an unmet medical need. 

A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.

The supply agreement with Eckert & Ziegler will ensure radiopharmaceuticals are available for PET imaging and cancer treatment plans.

The TAM-Sense technique is currently in pre-clinical development, but it could be used to develop new treatments.